StandardAero Adds $600M Term Loan to Fund $350M Accelerated Buyback
SARO sits 42% above its 52-week low of $19.56.
Summary
StandardAero priced a $600 million incremental term loan B and signed a $350 million accelerated share repurchase with Morgan Stanley, funding the buyback announced November 5. It is also seeking to extend its revolver by up to 18 months and add up to $250 million of commitments.
Key Events · Financing and Capital Events · SARO
-
$600M Incremental Term Loan B Priced
Amendment No. 1 to the October 31, 2024 credit agreement adds $434.7 million of U.S. dollar term B-1 loans and $165.3 million of Canadian term B-2 loans, for $600 million total, on the same terms and in the same class as the existing Initial Term B-1 and B-2 Loans.
-
$350M Accelerated Share Repurchase Signed
StandardAero will pay Morgan Stanley $350 million up front on November 16, 2026 and receive an initial delivery of about 80% of the expected shares, measured off the November 13, 2026 closing price; final settlement is expected no later than Q1 2027.
-
Buyback Funded With Debt and Cash
Proceeds of the incremental term facility may repay revolver borrowings and finance the $350 million repurchase, with the company stating it is funding the ASR using cash on hand and borrowings under the Incremental Term Facility.
-
Revolver Extension Proposed, Not Done
A Second Amendment would extend the revolver maturity by up to 18 months and add up to $250 million of incremental revolving commitments, subject to market conditions, requisite consents and lender commitments; no assurance it will be entered into.
Analysis · SARO · Manufacturing
StandardAero is borrowing $600 million of new senior secured term debt to pay down its revolver and fund the $350 million accelerated share repurchase it flagged on November 5. The buyback itself is not new, but the financing behind it is: the incremental term loans slot into the existing B-1/B-2 tranches on identical terms, so the company is adding leverage rather than using excess cash alone. The ASR delivers roughly 80% of the expected shares up front, with the final count set by the volume-weighted price through settlement (expected by Q1 2027) — meaning the actual share reduction is not yet fixed. Separately, the company is seeking a Second Amendment to extend the revolver by up to 18 months and add up to $250 million of commitments, which is only proposed and subject to lender consents. Net effect: a leveraged recapitalization that shrinks the equity base while increasing debt, against a backdrop of previously disclosed unremediated material weaknesses in internal controls.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SARO was trading at $27.73 on NYSE in the Manufacturing sector, with a market capitalization of approximately $9.1B. The 52-week trading range was $19.56 to $34.48. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.